Chad vs Kyrgyzstan: Previously treated cases tested for RR-/MDR-TB
Chad
95.0%
in 2024
Kyrgyzstan
95.0%
in 2024
Chad rank
66th
Kyrgyzstan rank
66th
Previously treated cases tested for RR-/MDR-TB over time
- Chad
- Kyrgyzstan
How they compare
Chad currently reports 95.0% against 95.0% in Kyrgyzstan, a difference of 0.0%.
The two have swapped places 2 times across 12 shared years of data; in 2010 it was Kyrgyzstan ahead.
Chad ranks 66th and Kyrgyzstan ranks 66th of 180 countries.
Across the 2 decades both report, Chad averaged higher in 1 and Kyrgyzstan in 1.
Head to head by decade
| Decade | Chad | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 24.0% | 63.9% | 39.9% | Kyrgyzstan |
| 2020s | 96.2% | 93.8% | 2.4% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Chad or Kyrgyzstan?
- Chad, at 95.0% against 95.0% in Kyrgyzstan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Chad and Kyrgyzstan?
- 0.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Kyrgyzstan?
- 12 years are reported by both, from 2010 to 2024.
- How do Chad and Kyrgyzstan rank globally for previously treated cases tested for rr-/mdr-tb?
- Chad ranks 66th and Kyrgyzstan ranks 66th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.